加载中
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
收盘时
US$1.40
−US$0.095 · -6.35%
盘后
US$1.43
+US$0.03 · +2.14%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日内区间
当前US$1.40
52周区间
当前US$1.40
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
52
合理估值
情绪
58
多空交织
风险
70
高风险
动量
31
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日内区间
当前US$1.40
52周区间
当前US$1.40
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CAD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 1531.94万 CAD | 2452万 CAD | 2451.8万 CAD | 2066.5万 CAD | 1936.4万 CAD |
| 销货成本 | 631.17万 CAD | 1097.2万 CAD | 1246.5万 CAD | 910.2万 CAD | 838.1万 CAD |
| 毛利 | 900.77万 CAD | 1354.8万 CAD | 1205.3万 CAD | 1156.3万 CAD | 1098.3万 CAD |
| 研究与开发 | 485.73万 CAD | 494.3万 CAD | 404.3万 CAD | 1410.1万 CAD | 766.3万 CAD |
| 销售、一般及管理费用 | 1885.83万 CAD | 1903.3万 CAD | 1913.5万 CAD | 1899.1万 CAD | 1805.5万 CAD |
| 营业费用 | 2371.56万 CAD | 2574.4万 CAD | 2581.5万 CAD | 3717.4万 CAD | 2765.6万 CAD |
| 利息收入 | — | — | 2.3万 CAD | 12.2万 CAD | 27.9万 CAD |
| 利息支出 | — | 9914 CAD | 1.9万 CAD | 3万 CAD | 8.5万 CAD |
| 折旧和摊销 | 157.94万 CAD | 511.9万 CAD | 573.5万 CAD | 668.5万 CAD | 376.9万 CAD |
| 营业利润 | −1470.79万 CAD | −1219.6万 CAD | −1376.2万 CAD | −2561.1万 CAD | −1667.3万 CAD |
| 净利润 | −1373.51万 CAD | −3023.4万 CAD | −2611.5万 CAD | −2656万 CAD | −1670.9万 CAD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
